After completing his formation in the Ecole Normale Supérieure Paris Saclay between 2013 and 2017, Erwan Morgand defended his master’s degree at the Université Paris Diderot in 2017.
He defended his Ph.D. in Immunology in 2022, working on colorectal precancerous lesions. His research is focused on developing a Digital Pathology axis in the Paris Transplant Group.